BeneDerma s.r.o.

At BeneDerma s.r.o. in Dubravka, clinical research in immune system diseases focuses on conditions such as chronic inducible urticaria and atopic dermatitis. These studies are designed to assess whether new treatment approaches can better control symptoms and improve day-to-day disease management for people whose conditions remain difficult to treat.

• Evaluating new treatment options for chronic inducible urticaria, including forms such as symptomatic dermographism, cold urticaria, and cholinergic urticaria
• Studying atopic dermatitis to see whether treatment changes can improve symptom control and overall effectiveness
• Assessing the safety and usefulness of therapies intended to better manage persistent immune-related skin symptoms

The site’s work in this area is centered on improving treatment response and finding options that may offer more consistent relief for patients with ongoing inflammatory disease.

Clinical trials at this hospital/clinic also address skin and connective tissue diseases, with a strong emphasis on nonsegmental vitiligo. Research here is exploring whether emerging therapies can help restore skin pigmentation and support longer-term disease control while maintaining acceptable safety and tolerability.

• Investigating treatment effectiveness in nonsegmental vitiligo, a condition marked by loss of skin color
• Measuring safety and tolerability over time for therapies aimed at improving visible skin repigmentation
• Examining whether adjusted treatment strategies can help patients achieve better skin-related outcomes

This research reflects a broader effort to advance care for chronic skin conditions where appearance, comfort, and long-term disease management all matter to patients.